Stay updated on ST-400 for TDT: Safety, Tolerability, and Efficacy Clinical Trial
Sign up to get notified when there's something new on the ST-400 for TDT: Safety, Tolerability, and Efficacy Clinical Trial page.

Latest updates to the ST-400 for TDT: Safety, Tolerability, and Efficacy Clinical Trial page
- CheckyesterdayChange DetectedThe government funding and operating status notice was removed from the page. The change does not affect the study data, eligibility criteria, or user actions on the ClinicalTrials.gov record.SummaryDifference0.4%

- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedThe updated screenshots show a rearranged layout and minor styling changes, with no alterations to critical study data such as eligibility criteria, locations, enrollment, or primary outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check45 days agoChange Detected- Added a government funding notice about potential delays and current operating status, plus a link to cc.nih.gov and opm.gov for updates. - Bumped version from v3.1.0 to v3.2.0.SummaryDifference4%

- Check52 days agoChange DetectedVersion bump to v3.1.0 and capitalization normalization from 'Beta thalassemia' to 'Beta Thalassemia'.SummaryDifference0.2%

- Check66 days agoChange DetectedUpdated to Revision v3.0.2; removed the v3.0.1 reference and the 'Back to Top' element. No other substantive changes detected.SummaryDifference0.3%

- Check73 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content, names, pricing, or availability.SummaryDifference0.3%

Stay in the know with updates to ST-400 for TDT: Safety, Tolerability, and Efficacy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ST-400 for TDT: Safety, Tolerability, and Efficacy Clinical Trial page.